What's Happening?
Newel Health, a digital medicine specialist, has partnered with Gerresheimer, a packaging group, to assist pharmaceutical companies in integrating digital technologies into clinical testing and developing new digital medical devices. This collaboration
aims to enable the deployment of integrated drug and digital therapies that facilitate real-world data generation and personalized medicine on a large scale. The partnership combines Newel Health's Software as Medical Device (SaMD) and AI platforms with Gerresheimer's expertise in drug delivery and primary packaging. This initiative is expected to help pharma companies design and scale digital endpoints, regulated digital medical devices, and integrated drug-digital solutions across various medical indications.
Why It's Important?
The collaboration between Newel Health and Gerresheimer is significant as it addresses the growing demand for personalized medicine and digital health solutions in the pharmaceutical industry. By leveraging digital technologies, the partnership aims to enhance patient adherence to treatments and provide valuable data to healthcare professionals. This could lead to more effective and personalized treatment options, improving patient outcomes. Additionally, the integration of digital endpoints and real-world data into clinical development and commercialization processes could streamline drug development and regulatory approval, potentially reducing costs and time to market for new therapies.
What's Next?
The partnership is expected to focus on designing and validating digital endpoints for clinical trials, utilizing connected devices and sensors. Newel Health's H-Core platform will be used to develop SaMDs for monitoring, decision-making, adherence tools, and symptom tracking. The collaboration will also work on building the digital infrastructure necessary to access real-world data and AI insights. As the partnership progresses, it may lead to the development of hybrid therapies that combine drug, device, and digital components, enhancing the overall effectiveness of treatments.
